Antibody

1,010개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,010 programs
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

ARX788 + Cemiplimab (ARX788 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Recruiting
AntibodyLimited DatastaleAntengene Therapeutics LimitedPhase 1

nivolumab (Opdivo, ATG-017+Nivolumab)

Solid Tumor; Hematological Malignancy · Solid Tumor

#SolidTumor#Antibody#Phase1#monoclonal-antibody#HematologicalMalignancy+1
Trials 1Status Discontinued
AntibodyLimited DatastaleUniversitair Ziekenhuis BrusselPhase 2

ATG-Rituximab-MMF-TAC (ATG-Rituximab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#monoclonal-antibody#DiabetesMellitus+2
Trials 1Status Active
AntibodyLimited DatastaleUniversitair Ziekenhuis BrusselPhase 2

ATG-basilixumab-MMF-TAC (ATG-basilixumab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#monoclonal-antibody#DiabetesMellitus+2
Trials 1Status Active
AntibodyLimited DatastaleAbbViePreclinical

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Preclinical#monoclonal-antibody#UlcerativeColitis+1
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 1

durvalumab (Imfinzi, AZD9150, Durvalumab)

Advanced Solid Malignancies · Advanced Solid Malignancies

#AdvancedSolidMalignancies#Antibody#Phase1#monoclonal-antibody#AstraZeneca
Trials 1Status Active
AntibodyLimited DatastaleTae Won KimPhase 2

atezolizumab (Tecentriq, Aatezolizumab plus Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#BispecificAntibodyAloneorwithChe+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol-Myers SquibbPhase 3

Abatacept (ABA, Abatacept, Abatacept (ABA) + Methotrexate (MTX), double-blind (DB))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Bristol-Myers
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Active bevacizumab and Active dexamethasone (Active bevacizumab and Active dexamethasone)

Non-Ischemic Central Retinal Vein Occlusion · Non-Ischemic Central Retinal Vein Occlus

#Non-IschemicCentralRetinalVeinOc#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleHanyang UniversityPreclinical

Adalimuab, Etanercept, Tocilizumab, or Abatacept (Adalimuab, Etanercept, Tocilizumab, or Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#Hanyang
Trials 1Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

Adebrelimab & SHR2554 (Adebrelimab & SHR2554)

Relapsed or Refractory Peripheral T Cell Lymphoma; NKTCL · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RelapsedorRefractoryPeripheralTC+2
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

Adebrelimab + Cetuximab+ Chemotherapy (Adebrelimab + Cetuximab+ Chemotherapy)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Active
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Active
AntibodyLimited DatastaleMedical College of WisconsinPhase 1

atezolizumab (Tecentriq, Adjuvant Atezolizumab)

Head and Neck Neoplasm · Head and Neck Neoplasm

#HeadandNeckNeoplasm#Antibody#Phase1#monoclonal-antibody#Medical
Trials 1Status Active
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

nivolumab (Opdivo, Adjuvant nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Ado-trastuzumab emtamsine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbViePhase 3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase3#monoclonal-antibody#Safety+1
Trials 1Status Active
AntibodyLimited DatastaleChinese Medical AssociationApproved

Akkermansia muciniphila + Infliximab (Akkermansia muciniphila + Infliximab)

Crohn's Diseases · Crohn's Diseases

#CrohnsDiseases#Antibody#Approved#monoclonal-antibody#Chinese
Trials 1Status Recruiting

17 / 51 pages

← PreviousNext →